Cresco Labs (CRLBF) Shares Outstanding (Weighted Average) (2019 - 2026)
Cresco Labs filings provide 8 years of Shares Outstanding (Weighted Average) readings, the most recent being $1.7 billion for Q1 2026.
- On a quarterly basis, Shares Outstanding (Weighted Average) rose 395.69% to $1.7 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $1.7 billion, a 395.69% increase, with the full-year FY2025 number at $1.7 billion, up 0.91% from a year prior.
- Shares Outstanding (Weighted Average) hit $1.7 billion in Q1 2026 for Cresco Labs, up from $1.7 billion in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $1.7 billion in Q1 2026 to a low of $90.0 in Q1 2022.
- Median Shares Outstanding (Weighted Average) over the past 5 years was $354.3 million (2025), compared with a mean of $917.6 million.
- The widest YoY moves for Shares Outstanding (Weighted Average): up 338565113.33% in 2023, down 99.98% in 2023.
- Cresco Labs' Shares Outstanding (Weighted Average) stood at $1.6 billion in 2022, then plummeted by 79.98% to $323.8 million in 2023, then skyrocketed by 427.09% to $1.7 billion in 2024, then grew by 0.91% to $1.7 billion in 2025, then grew by 0.8% to $1.7 billion in 2026.
- The last three reported values for Shares Outstanding (Weighted Average) were $1.7 billion (Q1 2026), $1.7 billion (Q4 2025), and $1.7 billion (Q3 2025) per Business Quant data.